<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Purpose </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0100280'>Crohn's disease</z:hpo> (CD) and <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> (UC), the two major forms of <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD), have histopathologically and immunologically different characteristics </plain></SENT>
<SENT sid="2" pm="."><plain>We previously reported that a traditional Japanese medicine, daikenchuto (TU-100), ameliorated a <z:chebi fb="0" ids="53063">trinitrobenzenesulfonic acid</z:chebi>- (<z:chebi fb="0" ids="53063,53506">TNBS</z:chebi>-) induced type-1 model <z:hpo ids='HP_0002583'>colitis</z:hpo> exhibiting histopathological features of CD through adrenomedullin (ADM) enhancement </plain></SENT>
<SENT sid="3" pm="."><plain>Our current aims were to examine whether TU-100 ameliorates a type-2 model <z:hpo ids='HP_0002583'>colitis</z:hpo> that histologically resembles UC and identify the active ingredients </plain></SENT>
<SENT sid="4" pm="."><plain>Methods </plain></SENT>
<SENT sid="5" pm="."><plain>TU-100 was administered orally to mice with <z:chebi fb="0" ids="53076">oxazolone</z:chebi>- (OXN-) induced type-2 model <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The morbidity was evaluated by body <z:hpo ids='HP_0001824'>weight loss</z:hpo> and the macroscopic score of colonic lesions </plain></SENT>
<SENT sid="7" pm="."><plain>ADM was quantified using an EIA kit </plain></SENT>
<SENT sid="8" pm="."><plain>Results </plain></SENT>
<SENT sid="9" pm="."><plain>TU-100 prevented <z:hpo ids='HP_0001824'>weight loss</z:hpo> and colon ulceration </plain></SENT>
<SENT sid="10" pm="."><plain>ADM production by intestinal epithelial cells was increased by TU-100 addition </plain></SENT>
<SENT sid="11" pm="."><plain>Screening to identify active ingredients showed that [6]-shogaol and hydroxy Î± -sanshool enhanced ADM production </plain></SENT>
<SENT sid="12" pm="."><plain>Conclusions </plain></SENT>
<SENT sid="13" pm="."><plain>TU-100 exerted a protective effect in OXN-induced type-2 model <z:hpo ids='HP_0002583'>colitis</z:hpo>, indicating that TU-100 may be a beneficial agent for treatment of UC </plain></SENT>
</text></document>